Corcept Therapeutics Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
Corcept Therapeutics · Relacorilant and related securities · Ongoing Litigation
Last updated
Case overview
- Defendant company
- Corcept Therapeutics
- Product or service
- Relacorilant and related securities
- Court case number
- 3:2026cv01525
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead Plaintiff Application
Participation information
Availability is based on each listed participation option and its deadline.
Lead Plaintiff Application
Investors who suffered losses on Corcept investments during the alleged class period may have been eligible to seek appointment as lead plaintiff.
Contact Glancy Prongay Wolke & Rotter LLP for information about participating or seeking appointment as lead plaintiff.
- Type
- Lead Plaintiff
- Status
- Deadline passed
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Corcept Therapeutics Securities Fraud Class Action
Barchart.com ·